“…The initial metabolism in gut is highly associated with CFs’ health‐promoting properties as this metabolic process can modify absorption of the parental compounds and metabolites might exhibit more or similar, or perhaps less bioactivities. Actually, emerging evidence suggests that in vivo metabolic processes, particularly transformation by gut microbiota, may elicit or enhance the intrinsic bioactivities of CFs, and have a positive impact on health (Chiou et al., 2014; Luca et al., 2020; Shakour, Fayek, & Farag, 2020; Wu, Song, Rakariyatham, Zheng, Wang, et al., 2015). In this context, it might not be difficult to understand the paradox of why CFs show a low oral bioavailability but afford a myriad of bioactivities.…”